Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,655   13.81  Index Moved Down -0.83%
PTI NDQ TLB OMG Diversified Assets Manufacturing Plastics Air 
United States GSPC USD ...  |  Company Directory


Processing
Processing. Please wait...

Patheon insider: Rebecca New

       

Rebecca New - Patheon Insider Profile

Senior Vice President - Human Resources

Ms. Rebecca Holland New is Senior Vice President Human Resources of Patheon Inc., since August 2011. Most recently, from November 2007 to July 2011, Ms. Holland New was Global Vice President, Human Resources at Bausch & Lomb, Inc. Prior to that, from April 2007 to October 2007, Ms. Holland New held global human resources leadership positions at Bausch & Lomb?s business operations, talent, corporate and pharmaceutical business units as well as global research and development. Prior to joining Bausch & Lomb, Ms. Holland New held human resources leadership positions at Novo Nordisk, Inc., from November 2003 to April 2007, and BristolMyers Squibb, from August 1996 to November 2003. Ms. Holland New is an Advisory Member for Cornell University?s Industrial and Labor Relations Professional Development Initiatives.
Age: 37  President Since 2011      
905-812-2125  http://www.patheon.com

Other Appointments

Patheon IncPNHNFUnited States OTC
President since 2011
Patheon IncPNHNFUnited States OTC
President since 2011

Management Efficency

The company has return on total asset (ROA) of 3.86 % which means that it generated profit of $3.86 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of (85.87) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 589.6 M in total debt with debt to equity ratio (D/E) of 5.1 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Patheon Inc has Current Ratio of 1.69 which is within standard range for the sector.
    

Other Executives

James Mullen, CEO
Paul Levy, Chairman
Warren Horton, President
Aqeel Fatmi, President, Ph.D
Harry Gill, President
Antonella Mancuso, President
Michael Lehmann, President, MBA
Geoffrey Glass, President
Aqueel Fatmi, President, Ph.D
Michael Lytton, President
Stuart Grant, CFO
Paul Garofolo, CTO
Michael JD, EVP
Derek Watchorn, Director

Entity Summary

Patheon Inc. offer drug development and manufacturing services to the pharmaceutical, biotechnology, and specialty pharmaceutical companies worldwide. Patheon Inc [PTI] is traded on Toronto Stock Exchange in Canada. It is located in Mississauga, ON LN K and employs 4,700 people. Filter other
    
Specify Title
Indicate Tenure
Select Industry
Click to run this filter
 Run Equity Filter
Filter Other Insiders
 
    
    
PTI Canada Toronto #2731579CA
Patheon Inc
Benchmark S&P 500
Currency: CAD - Canadian Dollar
Traded on Toronto Stock Exchange
    
    
Chance of
Bankruptcy
Less
Than
47%
In The Next
Two Years
Patheon Inc has less than 47.0 (%) percent chance of experiencing financial distress in the next 2 years of operations.
    
    

Patheon price boundaries

    
April 23 2013
 4.33 
  
 4.30 
(0.03)  Macroaxis: -0.692840646651276 Down   0.69%  
Lowest period price (30 days)
May 22 2013
 5.62 
  
 5.68 
0.06  Macroaxis: 1.0676156583629823 Up   1.07%  
Highest period price (30 days)
    

Promote Patheon and Rebecca New

Follow Patheon with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Patheon to your reader
 

Today Change

 thisGreen PTI PTI.TO agains markets  0.35 % Macroaxis: 0.35 Moved Up  
 
 Canada Canada   0.08 % Macroaxis: 0.08 Moved Up  
 
 United States SP 500   0.83 % Macroaxis: 0.83 Moved Down  
 

Stock Performance

Shares Outstanding139.81 M


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium